Published in J Intern Med on September 01, 1998
The risk and prognosis of cancer after hospitalisation for herpes zoster: a population-based follow-up study. Br J Cancer (2004) 1.13
Cancer-associated hypercalcemia treated with intravenous diphosphonates: a survival and prognostic factor analysis. Support Care Cancer (2007) 1.00
Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med (1997) 10.83
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet (1999) 8.44
Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ (2000) 2.80
Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model. Pharmacol Toxicol (2001) 2.34
Patient's and doctor's delay in primary breast cancer. Prognostic implications. Acta Oncol (1994) 2.27
[Improved prognosis of breast cancer]. Ugeskr Laeger (1994) 2.21
Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr (1992) 1.93
High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res (1993) 1.86
The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG). Breast Cancer Res Treat (1994) 1.69
Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer. J Clin Oncol (1987) 1.59
Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer co-operative Group DBCG 82B Trial. Eur J Cancer (1999) 1.55
Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas. Eur J Cancer Clin Oncol (1987) 1.53
Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer. Cancer Res (1987) 1.53
Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis. Int J Geriatr Psychiatry (2008) 1.51
Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival. Cancer J Sci Am (2006) 1.43
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients. Eur J Cancer (2002) 1.41
[Treatment of primary breast cancer. Consequences of mammographic screening in the municipality of Copenhagen]. Ugeskr Laeger (1996) 1.38
Should women be advised against pregnancy after breast-cancer treatment? Lancet (1997) 1.26
Danish Breast Cancer Cooperative Group (DBCG). A description of the register of the nation-wide programme for primary breast cancer. Acta Oncol (1988) 1.21
[Mammographic examinations in Denmark, 1990-1991]. Ugeskr Laeger (1994) 1.19
Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer (1992) 1.18
Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer. J Natl Cancer Inst (1991) 1.18
DNA-binding proteins in Yoshida ascites tumor fluid. Biochim Biophys Acta (1976) 1.17
The biotransformation of cyclophosphamide in man: analysis of the variation in normal subjects. Acta Pharmacol Toxicol (Copenh) (1974) 1.15
Time since childbirth and prognosis in primary breast cancer: population based study. BMJ (1997) 1.13
Oral clodronate in breast cancer patients with bone metastases: a randomized study. J Intern Med (1999) 1.10
Parity, age at first childbirth and the prognosis of primary breast cancer. Br J Cancer (1998) 1.10
Adjuvant radiotherapy and risk of contralateral breast cancer. J Natl Cancer Inst (1992) 1.10
Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study. J Alzheimers Dis (2007) 1.08
Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study. J Clin Oncol (1994) 1.06
Danish Breast Cancer Cooperative Group (DBCG). Structure and results of the organization. Acta Oncol (1988) 1.05
Grading of soft tissue sarcomas: experience of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer (1993) 1.03
Second cancer following cancer of the female breast in Denmark, 1943-80. Natl Cancer Inst Monogr (1985) 1.03
Mitoxantrone for the treatment of advanced breast cancer: single-agent therapy in previously untreated patients. Eur J Cancer Clin Oncol (1984) 1.03
Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer. Eur J Cancer (1995) 1.03
Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study. J Alzheimers Dis (2008) 1.03
Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables?--a population-based study. Eur J Cancer (2004) 1.02
Therapeutic effect of tamoxifen alone versus tamoxifen in combination wtih gestagen and oestrogen in advanced breast cancer. Recent Results Cancer Res (1980) 1.02
Inter- and intraobserver variability in the histopathological diagnosis of medullary carcinoma of the breast, and its prognostic implications. Breast Cancer Res Treat (1989) 1.01
Organisation of the Danish adjuvant trials in breast cancer. Dan Med Bull (1981) 1.01
Metastatic pattern in recurrent breast cancer. Special reference to intrathoracic recurrences. Cancer (1988) 1.01
Anxiety and depression in breast cancer patients at low risk of recurrence compared with the general population: a valid comparison? J Clin Epidemiol (1999) 0.99
The pattern of metastases in human breast cancer. Influence of systemic adjuvant therapy and impact on survival. Acta Oncol (1988) 0.98
Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group. Cancer Chemother Pharmacol (1993) 0.97
Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values. Lancet (1985) 0.97
The present state of the art in chemotherapy for soft tissue sarcomas in adults: the EORTC point of view. Crit Rev Oncol Hematol (1995) 0.96
Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma Group. Cancer (1984) 0.96
Comparative pharmacokinetics of medroxyprogesterone acetate administered by oral and intramuscular routes. Cancer Chemother Pharmacol (1980) 0.96
Cyclophosphamide versus ifosfamide: preliminary report of a randomized phase II trial in adult soft tissue sarcomas. Cancer Chemother Pharmacol (1986) 0.96
Pattern of spread and progression in relation to the characteristics of the primary tumour in human breast cancer. Acta Oncol (1991) 0.95
The metabolism of cyclophosphamide. Dose dependency and the effect of long-term treatment with cyclophosphamide. Cancer (1976) 0.94
Quality control of end results in a Danish adjuvant breast cancer multi-center study. Acta Oncol (1997) 0.94
Decreased efficacy of cyclophosphamide, epirubicin and 5-fluorouracil in metastatic breast cancer when reducing treatment duration from 18 to 6 months. Eur J Cancer (1993) 0.93
Antiestrogen treatment of postmenopausal women with primary high risk breast cancer. Breast Cancer Res Treat (1983) 0.93
The presence of tumor cells in bone marrow at the time of first recurrence of breast cancer. Cancer (1987) 0.93
BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age. J Med Genet (2001) 0.92
A randomized study of epirubicin at four different dose levels in advanced breast cancer. Feasibility of myelotoxicity prediction through single blood-sample measurement. Cancer Chemother Pharmacol (1991) 0.92
Prognostic factors in osteosarcomas. A regression analysis. Cancer (1988) 0.91
Clinical and histopathological prognostic factors in chondrosarcomas. Sarcoma (1997) 0.91
Carminomycin vs adriamycin in advanced soft tissue sarcomas: an EORTC randomised phase II study. Eur J Cancer Clin Oncol (1983) 0.91
Risk of late-stage breast cancer after a childbirth. Am J Epidemiol (2001) 0.90
alpha-fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence. J Natl Cancer Inst (2000) 0.90
High-dose DTIC in advanced soft-tissue sarcomas in the adult. A phase II study of the E.O.R.T.C. Soft Tissue and Bone Sarcoma Group. Ann Oncol (1991) 0.90
Timing of surgery in relation to menstrual cycle does not predict the prognosis in primary breast cancer. Danish Breast Cancer Cooperative Group. Eur J Surg Oncol (1994) 0.89
The extravascular retention of albumin in wound tissue and its contribution to the postoperative hypoalbuminaemia in rabbits. Clin Sci (1969) 0.89
A Danish randomized trial comparing breast-preserving therapy with mastectomy in mammary carcinoma. Preliminary results. Acta Oncol (1988) 0.89
The biotransformation of cyclophosphamide in man: influence of prednisone. Acta Pharmacol Toxicol (Copenh) (1974) 0.89
Ifosfamide plus doxorubicin in previously untreated patients with advanced soft tissue sarcoma. The EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer (1990) 0.89
Reduced mortality for women with mammography-detected breast cancer in east Denmark and south Sweden. Eur J Cancer (2006) 0.88
Treatment of metastatic breast cancer with paclitaxel and doxorubicin. Semin Oncol (1995) 0.88
Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function. Eur J Clin Pharmacol (1989) 0.88
Adjuvant endocrine therapy of breast cancer--a controlled clinical trial of oestrogen and anti-oestrogen: preliminary results of the Copenhagen breast cancer trials. Recent Results Cancer Res (1980) 0.88
Adjuvant systemic therapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group's trials of cyclophosphamide or CMF in premenopausal and tamoxifen in postmenopausal patients. Recent Results Cancer Res (1984) 0.87
Danish Breast Cancer Cooperative Group (DBCG). Present status and experience. Acta Chir Scand Suppl (1984) 0.87
Femoral fractures in postmenopausal breast cancer patients treated with adjuvant tamoxifen. Breast Cancer Res Treat (1996) 0.87
Symptoms of endocrine treatment and outcome in the BIG 1-98 study. Breast Cancer Res Treat (2013) 0.86
Endocrine therapy of advanced breast cancer. Acta Oncol (1988) 0.86
Short-term treatment with gaboxadol improves sleep maintenance and enhances slow wave sleep in adult patients with primary insomnia. Psychopharmacology (Berl) (2007) 0.86
Histological grade and steroid receptor content of primary breast cancer--impact on prognosis and possible modes of action. Br J Cancer (1988) 0.86
Plasminogen activator inhibitor type 1 in cytosolic tumor extracts predicts prognosis in low-risk breast cancer patients. Clin Cancer Res (1997) 0.86
Chemotherapy and survival in breast cancer. Lancet (1980) 0.86
The complex between urokinase and its type-1 inhibitor in primary breast cancer: relation to survival. Cancer Res (2000) 0.85
Incidence and methodologic aspects of the occurrence of liver metastases in recurrent breast cancer. Cancer (1987) 0.85
Do clinical databases render population-based cancer registers obsolete? The example of breast cancer in Denmark. Cancer Causes Control (2000) 0.85
Malignant haemangiopericytomas and haemangioendotheliosarcomas: an immunohistochemical study. Histopathology (1988) 0.85
Mitoxantrone as first-line chemotherapy in advanced breast cancer: results of a collaborative European study. Invest New Drugs (1985) 0.84
Lu 25-109, a muscarinic agonist, fails to improve cognition in Alzheimer's disease. Lu25-109 Study Group. Neurology (2000) 0.84
Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer. EORTC Breast Cancer Cooperative Group. Br J Cancer (1998) 0.84
Carcinogenic effects of adjuvant tamoxifen treatment and radiotherapy for early breast cancer. Acta Oncol (1992) 0.84
Efficacy of intravenous citalopram compared with oral citalopram for severe depression. Safety and efficacy data from a double-blind, double-dummy trial. J Affect Disord (2000) 0.83
Pharmacokinetics of medroxyprogesterone acetate administered by oral and intramuscular route. Acta Obstet Gynecol Scand Suppl (1981) 0.83
Reproductive history and stage of breast cancer. Am J Epidemiol (1999) 0.83